TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
795
|
772
|
832 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
134
|
246
|
205 |
| EBITDA |
128
|
229
|
209 |
| Total assets |
1,183
|
1,206
|
1,376 |
| Current assets |
839
|
1,014
|
1,283 |
| Current liabilities |
137
|
43
|
68 |
| Equity capital |
965
|
1,090
|
1,134 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
81.6%
|
90.4%
|
82.4% |
| Turnover per employee |
795
|
772
|
832 |
| Profit as a percentage of turnover |
16.9%
|
31.9%
|
24.6% |
| Return on assets (ROA) |
11.3%
|
20.5%
|
15.0% |
| Current ratio |
612.4%
|
2358.1%
|
1886.8% |
| Return on equity (ROE) |
13.9%
|
22.6%
|
18.1% |
| Change turnover |
19
|
7
|
-264 |
| Change turnover % |
2%
|
1%
|
-24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.